At COO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based COO’ operating in the Health Diagnostics space. If you think a COO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Howard Dubinett
EVP & COO of Bio-Reference Laboratories
Follow Howard Dubinett:
About Bio-Reference Laboratories: BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing .
Tomer Jackman
Co-founder and COO of Variantyx
Tomer serves as the Chief Operating Officer of Variantyx and is responsible for delivering services to customers. This includes day-to-day operations such as supply chain management, customer care, and above all, productivity. Prior to co-founding Variantyx, Tomer was responsible for hardware development operations in Pivotal/Greenplum division of EMC2 where he helped develop server clusters for “Massive Parallel Processing” databases. This followed a decade with EMC2 in several hardware engineering roles, and work in R&D with HP/Indigo. He holds a high-tech MBA from Northeastern University in Boston, and a BSc in Electrical Engineering from Tel-Aviv University.
Follow Tomer Jackman:
About Variantyx: Variantyx offers a comprehensive set of advanced genomic diagnostic products and services with a focus on whole genome sequencing.
Aaron Sheedy
Chief Operating Officer of Xealth
Mr. Aaron Sheedy serves as Chief Operating Officer at Xealth Inc.
Follow Aaron Sheedy:
About Providence Health & Services, Xealth: Xealth is a platform for digital health, enabling clinicians to prescribe and monitor digital tools from within the EHR workflow.
Gene Castagnini
COO, CFO, CAO & Co-founder of Biocare Medical
Gene J. Castagnini, MS, MBA, co-founded Biocare Medical LLC in 1997 and serves as its Co-Owner and Chief Financial Officer. Gene Castagnini serves as the Chief Operating Officer and Executive Vice President of Biocare Medical, LLC Gene Castagnini served as the Chief Administrative Officer and Chief Financial Officer of BioGenex Laboratories. Inc., for 10 years. Gene Castagnini’s experience includes 15 years as a Director and Officer of Medi-Physics Inc., formerly a Hoffmann-La Roche Inc. subsidiary. Gene Castagnini has a BS in accounting and an MBA in Human Resource Management from the California State University school systems.
Follow Gene Castagnini:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Julie Skaff
Chief Operating Officer of Viz
Julie is Head of Operations at OODA Health.Prior to OODA she served as the Vice President of Implementation & Account Management at Grand Rounds, Inc. She managed the growth in their customer base to more than 80 direct customers. Prior to Grand Rounds, Julie was the Director of Implementation at Castlight Health, where she led the strategic implementation group. Julie has also worked in Booz & Company’s Global Health Practice and served Senator Dianne Feinstein as an aide for taxes, budget, and commerce. Julie has an MBA from the Tuck School of Business at Dartmouth and a BA from Northwestern University.
Follow Julie Skaff:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Riley Ennis
Co-Founder and COO of Freenome
Riley is a Thiel Fellow who created a cancer vaccine with his previous company Immudicon as Co-Founder & Chair. Co-Founder, COO at Freenome.
Follow Riley Ennis:
About Freenome, Immudicon, Oncolinx, The Thiel Foundation: Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.
Jason Cole
Chief Operating and Legal Officer of Bluebird Bio
Follow Jason Cole:
About Bluebird Bio: Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Michael McKenna
President & COO of Quantum SI
Michael McKenna is the President and Chief Operating Officer of Quantum-Si since December 2014. Prior to joining Quantum-Si, Dr. McKenna served as Vice President, R&D at Life Technologies Corporation, a global biotechnology company, from August 2011 to July 2014, and as a consultant to Life Technologies from February 2011 to August 2011. Dr. McKenna received his B.S. in molecular biology and German from Carnegie Mellon University and his Ph.D. in biology from Yale University.
Follow Michael McKenna:
About Quantum SI: Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
Jonathan Lanfear
Chief Operating Officer of HiberCell
Follow Jonathan Lanfear:
About HiberCell: HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Dave Anderson
Senior VP of Engineering & Chief Operating Officer of Atonarp
Follow Dave Anderson:
About Atonarp: Atonarp combines electronics and data processing algorithms for chemical composition analysis.
Jihye Shin
Co-founder & COO of GIBLIB
Follow Jihye Shin:
About GIBLIB: GIBLIB is a California-based company and is the “Netflix” of Medical Education.
Tayson Siegel
Chief Operating Officer of Xip
Follow Tayson Siegel:
About Xip: Xip produces disposable blood analyzers that wirelessly upload lab-quality clinical measurements in minutes.
Frank Thomas
President & Chief Operating Officer of Orchard Therapeutics
Frank brings nearly 20 years of experience in the biopharmaceutical industry as an accomplished financial and business executive. Frank has a background developing and executing capital markets strategies for private and public companies as well as experience in operations management, and corporate and business development. Until recently Frank served as president and chief operating officer of AMAG Pharmaceuticals where he helped develop the business from a single product company in 2011 to one with a portfolio of commercial and development-stage products that generated more than $600 million in sales in 2017. During that time, Frank raised more than $1.8 billion in new capital to support the significant growth of AMAG. Before joining AMAG, he served as chief operating officer and chief financial officer for Molecular Biometrics, Inc. Earlier in his career, Frank also served as chief financial officer for Critical Therapeutics and Esperion Therapeutics. Each completed its initial public offering in the United States during his tenure. Frank currently serves on the board of directors of Zafgen (Nasdaq: ZFGN) and Spero Therapeutics (Nasdaq: SPRO). Frank received a Bachelor of Business Administration (BBA) from the University of Michigan, Ann Arbor.
Follow Frank Thomas:
About Orchard Therapeutics: Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients through innovative gene therapies.
Fred Daugherty
Chief Operating Officer of CSI Laboratories
Fred Daugherty is Chief Operating Officer at CSI Laboratories.
Follow Fred Daugherty:
About CSI Laboratories: CSI Laboratories has provided pathologists and clinicians with the diagnostic expertise.
Anthony Gabriel
COO of Radiology Partners
Anthony graduated with his medical degree from The Ohio State University and became a clinical instructor at UCLA Medical Center in 1993. While a practicing physician, Anthony earned his MBA from the University of California, Los Angeles, Anderson School of Management and then joined DaVita Inc. (now DaVita Healthcare Partners). During his time with DaVita, Anthony was promoted from vice president of commercial patients to COO, integration and managed the integration of Gambro Healthcare, which doubled the size of DaVita. In 2008, Anthony rose to CIO leading 1,000 teammates, 300 contractors and $150 million budget developing several new systems for DaVita. Anthony cofounded Radiology Partners in 2012.
Follow Anthony Gabriel:
About Radiology Partners: Radiology Partners is a healthcare service company focused on transforming how services are provided by radiologists.
Justin Geller
Co-Founder and COO of Monument
James Goldman is the Co-Founder and Advisor at Paintzen and Co-Founder and COO of Monument.
Follow Justin Geller:
About Monument, Paintzen: Monument is an alcohol addiction treatment platform for those looking to change their relationship with alcohol.
Shaokang Wang
Co-founder and COO, Data Modeler of Infervision
Shaokang Wang is the co-founder,COO, and data modeler. Before starting Tuixiang, he worked as a data scientist in the Anthem Marketing Solutions, responsible for business and market analysis. He got his master degree of statistics at the University of Chicago.
Follow Shaokang Wang:
About Infervision: Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Kristy Campbell
Chief Operating Officer of Rev1 Ventures
Kristy Campbell has dedicated her 20+ year career to working with – and within – tech startups to help them build their brand, grow revenue and scale. As the Chief Operating Officer at leading venture development fund, Rev1 Ventures, Campbell supports the company’s mission to help entrepreneurs build great companies. Tapping into her longevity in the industry, she helps guide startups in their critical first phases of growth to expedite their success and ensure they are poised for scalable growth. Kristy has a BS in Journalism from Ohio University and an MBA from Ashland University.
Follow Kristy Campbell:
About Rev1 Ventures: Rev1 Ventures is an investor startup studio that combines capital and strategic services to help startups scale and corporates innovate.
A. Zaki Sabet
Co-Founder and COO of Precipio Diagnostics
A. Zaki Sabet has been with Precipio since co-founding the company in 2011 and currently serves as the Chief Operating Officer. He holds over 12 years of experience in laboratory management spanning all fields of reference laboratory operations primarily focusing on cancer diagnostics. Prior to Precipio, Zaki has served as a consultant with the College of American Pathologists (CAP) for many years as well as several diagnostic companies in setting up their specialized cancer testing operations. Zaki holds a Bachelor of Science degree in Biomedical Engineering from the New Jersey Institute of Technology.
Follow A. Zaki Sabet:
About Precipio Diagnostics: Precipio Diagnostics is a cancer diagnostics reference laboratory delivering advanced diagnostics, advice and personalized medicine.
Kristen Kerns
Chief Operating Officer of ConcertoCare
Kristen Kerns is the Chief Operating Officer at Concerto Healthcare. She has held various positions at Oak Street Health and Enlivant. Kristen attained an MBA degree in health enterprise management and a BS degree in industrial and systems engineering.
Follow Kristen Kerns:
About ConcertoCare: ConcertoCare is a provider of comprehensive care for seniors and other adults.
Christopher G. Lafarge
COO of MedicaMetrix
A.B., Biology, Harvard College; MBA, Yale University; MFS, Yale University. Mr. LaFarge has been the Founder/CEO of companies in several industries including forest products, oil and gas, and healthcare. He has successfully created, developed and brought to market a number of new products. He grew his last company to a $50M pre-money valuation before selling it to a fortune 500 company. Mr. LaFarge spent 4 years at Harvard Medical School and Beth Israel Hospital doing biomedical research.
Follow Christopher G. Lafarge:
About MedicaMetrix: Advancing Prostate Disease Management
Ray Farnham
COO of GraftWorx
Follow Ray Farnham:
About GraftWorx: GraftWorx is turning the Internet of Things into the Internet of the Body.
Nico Choksi
COO of Epitel
Nico is COO at Epitel. Epitel is changing the way we diagnose and manage neurological disorders in-hospital and at home, starting with seizures. Nico was previously an investor at Unilever Ventures, focusing on enterprise technology, new commerce models, and consumer brands. He managed Unilever Ventures’ investment in CreatorIQ and was involved with Zitsticka, Jellysmack, WeGift, and True Botanicals. Nico has helped set up a venture capital seed fund, invested with London-based seed fund Force Over Mass, and helped B2B and B2C start-ups raise VC funding. He was previously a healthcare consultant in DC and the Bay Area. Nico has an MBA from London Business School and is a former Fellow of the Ellen MacArthur Foundation.
Follow Nico Choksi:
About Epitel: Epitel is empowering clinicians, patients, and caregivers who live with or care for neurological disorders with wearables and powerful AI.
Mike Pickering
COO/EVP of Ingenious Med
Investor, Entrepreneur, Sr Executive, Software Developer
Follow Mike Pickering:
About Ingenious Med: Ingenious Med develops and delivers inpatient practice management information systems in the United States.
Anthony Bellezza
President and COO of Third Eye Diagnostics
Anthony Bellezza, PhD (Chief Operating Officer) has spent much of his career studying the mechanical properties of the eye, especially in response to changes in intraocular pressure. His research experience includes studies that quantify the biomechanical properties of the optic nerve head in glaucoma, the design of imaging systems to produce three-dimensional reconstructions of the optic nerve head, and the use of materials testing systems to characterize the properties of soft tissue. Prior to Third Eye Diagnostics, Dr. Bellezza was a Senior Engineer at Exponent, Inc., where he was a consultant in the Injury Biomechanics and Medical Device Practices. He has managed over 200 projects for Fortune 100 companies and has been an testifying expert in cases of ocular and head injury. Dr. Bellezza holds academic appointments as a Visiting Lecturer in the Department of Mechanical and Aerospace Engineering at Princeton University, and as an Adjunct Professor in the School of Engineering at Widener University.
Follow Anthony Bellezza:
About Third Eye Diagnostics: Third Eye Diagnostics develops a non-invasive intracranial pressure monitor that gathers information from the patient’s eye.
Dave Messina
Chief Operating Officer of Cofactor Genomics
Dr. David Messina has spent the last 20 years in computational biology and genetics. He worked on the Human Genome Project at Washington University in Saint Louis, mapped disease genes at the University of Chicago, and co-developed the first comprehensive atlas of human transcription factor genes. As COO of Cofactor Genomics, Dr. Messina is pioneering the use of RNA-based diagnostics, enabling personalized treatment for patients.
Follow Dave Messina:
About Cofactor Genomics, Pioneer Fund: Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Grace Wei
COO, Founder, PhD of Encellin
Follow Grace Wei:
About Encellin: Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.
Piyush Sadana
Co-Founder and COO of RICOVR Healthcare Inc.
Piyush Sadana is the Co-Founder and Chief Operating Officer of Ricovr Healthcare.
Follow Piyush Sadana:
About RICOVR Healthcare Inc.: RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
Bernardino Iliakis
COO of CorneaGen
Follow Bernardino Iliakis:
About CorneaGen, CorneaGen: CorneaGen innovates cornea care, from new medical devices and biologics to therapeutics and interventions.
Shenda Baker
President, Chief Operating Officer of Synedgen
Shenda Baker joined Synedgen as President and CEO in 2019.Dr. Shenda Baker has more than 20 years of experience conducting, generating funds for, and directing chemistry, materials science, and biochemistry research. She provides scientific leadership, manages the intellectual property as well as the scientific and regulatory collaborations, and provides financial and organizational oversight at Synedgen. Previously, Dr. Baker was a professor of Chemistry at Harvey Mudd College from 1991-2014. She served on the Board of Directors of the Materials Research Society and has served on advisory boards with the National Institutes of Health, National Science Foundation and the Department of Energy. She is co-inventor on all of the Synedgen technology.
Follow Shenda Baker:
About Harvard Innovation Labs, Prisyna, Synedgen, Synspira: Synedgen develops novel therapies and products to reduce infection and inflammation of dermal, oral, mucosal, and ophthalmic surfaces.
John Cole
founder & COO of AffirmHealth
Follow John Cole:
About AffirmHealth: Our advance care planning software helps providers generate revenue, increase patient satisfaction, and improve population health.
Alexander Schuth
COO & Head of Corporate Development of Denali Therapeutics
Alexander Schuth is the COO at Denali Therapeutics
Follow Alexander Schuth:
About Denali Therapeutics: Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Sanjay Rao
Co-Founder and COO of DeepRed Technologies
Follow Sanjay Rao:
About DeepRed Technologies: DeepRed Technologies develops applications in healthcare, energy, manufacturing, and artificial intelligence.
Ron Louks
Chief Operating Officer of NantHealth
Ron Louks serves as chief operating officer at NantHealth,where he oversees global operations. Bringing an extensive experience scaling businesses, Ron was appointed in the company in May 2017. Prior to that, he served as president of devices and emerging solutions at BlackBerry. He was also a CEO at OpenNMS Group and a CSO at HTC Corporation.
Follow Ron Louks:
About NantHealth: NantHealth is a healthcare company providing an evidence-based platform for healthcare diagnostics.
Rick Pharr
COO of Kipu Health
Follow Rick Pharr:
About Kipu Health: SaaS platform for behavioral health and addiction treatment centers providing EHR, patient engagement and RCM solutions.
Mark Hazeltine
Chief Operating Officer of Exagen
Mark Hazeltine has served as our Chief Operating Officer since March 2021 and served in multiple key leadership roles including General Manager, Senior Vice President of Finance and Corporate Development, VP of Finance, and Sr. Director of Financial Planning & Analysis since 2015. Prior to joining Exagen, Mr. Hazeltine served as Director of Financial Planning and Analysis and Director of Financial Business Processes at CareFusion, a medical technology corporation. Mr. Hazeltine also worked in multiple management roles at multinational organizations including Kyocera and Qualcomm. Mr. Hazeltine received his Bachelor of Business Administration degree from the University of San Diego and Master of Business Administration degree from the Marshall School of Business at the University of Southern California.
Follow Mark Hazeltine:
About Exagen: Exagen is a patient focused, discovery-driven life science company serving patients affected by autoimmune rheumatic diseases.
Roy Hess
COO, CFO, Founder of RadSupport, Inc.
Follow Roy Hess:
About RadSupport, Inc.: Deep Learning Computer Aided Diagnosis
Richard P. Zemsky
Co-Founder and COO of Neurovation Labs
Richard P. Zemsky, an attorney and entrepreneur, is co-founder and Chief Operations Officer of Neurovation Labs. Mr. Zemsky received a B.S. in Mechanical Engineering from Villanova University before graduating from Columbia Law School. He founded Sproute Travel, a tech company for travel recommendations and trip planning. Richard has previously conducted research in heat transfer theory, shape memory alloy-based robotic design, and sediment accumulation on mid-ocean ridges, and served as team lead for mechanical and aeronautical design for a vertical take-off and landing electric aircraft. As an attorney he focused on patent law across a range of technologies, advising early stage and established companies in the development, protection, and enforcement of their intellectual property rights. Mr. Zemsky is a presenter at national biotech and law conferences and has spoken on intellectual property panels as it pertains to the healthcare industry.
Follow Richard P. Zemsky:
About Aimecast, Neurovation Labs: Neurovation Labs is a biotech company focused CNS disorders, starting first with Post-traumatic Stress Disorder (PTSD).
Melinda Thomas
COO and Co-Founder of Octave Bioscience
Melinda Thomas currently works as Chief Operating Officer and Co-Founder at Octave Bioscience.
Follow Melinda Thomas:
About Octave Bioscience: Octave Bioscience an early stage molecular diagnostics company focused on neurodegenerative diseases and conditions.
Hossein Maleknia
Chief Operating Officer of Magellan Diagnostics
Hossein joined Magellan in January 2012, as Chief Operating Officer. Prior to taking on this role, he worked for ThermoFisher/Dionex and ESA Biosciences as General Manager and Director of Engineering, and as Vice President of Operations, from April 2007 through December 2011. Earlier in his career, Hossein was the Director of Operations at Instrumentation Laboratory for 14 years, where he headed all instrument and sensor manufacturing operations, and led the consolidation of three International and US sites to Lexington, Massachusetts. He was also the Group Manager of Baxter MicroScan in Sacramento, California. Hossein earned his BS and Master’s degrees in Mechanical Engineering from the University of Bridgeport, Connecticut.
Follow Hossein Maleknia:
About Magellan Diagnostics: Magellan Biosciences is provider of point-of-care analyzers and automated systems for hospital-based labs and near-patient testing.
Laurie Huard
Chief Operating Officer of Clinical Genomics Technologies
Follow Laurie Huard:
About Clinical Genomics Technologies: Clinical Genomics develops innovative products for colorectal cancer diagnosis.
Matthew Chen
Co-Founder and COO of Moichor
Matthew Chen is the Co-Founder and COO at Moichor.
Follow Matthew Chen:
About Moichor: The next generation of animal diagnostics.
Marcus Grindstaff
Chief Operating Officer of Care Innovations
Marcus Grindstaff is a business strategy and product technology leader with more than 20 years of experience in the high tech industry. Marcus is currently the Chief Operating Officer, and has responsibility for Care Innovations sales and operations. Prior to this role, Marcus held several roles at Care Innovations including Vice President, Sales and Market Development. Marcus joined Care Innovations at its formation in 2011, from the Intel Digital Health Group. A 17-year Intel veteran, Marcus held a variety of positions including leadership roles in both Intel Capital and Intel’s core semiconductor business. Marcus also served as the Technology Director in Intel’s Ultra-mobility Office of Big Ideas, where he was responsible for building the Low Power Chipset team, delivering Intel’s first low power chipset for the Atom* microprocessor. Throughout his career, Marcus has focused on growing exceptional teams chartered with delivering strategy, technology, marketing and product execution throughout the U.S., Asia and Europe. He is also a passionate spokesperson for reforming the healthcare delivery system, and serves on the board of the National Alliance for Caregiving.
Follow Marcus Grindstaff:
About Care Innovations: Care Innovations provides technology-based healthcare management services designed to connect people to care givers.
Mike Steen
Chief Operating Officer of Trice Medical
Mike Steen is the Chief Operating Officer at Trice Medical.
Follow Mike Steen:
About Trice Medical: Trice Medical specializes in providing solutions for orthopedic diagnostics.
Dan Kincaid
President and Chief Operating Officer of Sense Neuro Diagnostics
Dan Kincaid is the President and Chief Operating Officer of Sense Neuro Diagnostics.
Follow Dan Kincaid:
About Queen City Angels, Sense Neuro Diagnostics: Sense Neuro Diagnostics is a developer of non-invasive medical devices for neurological conditions.
Winston P. Kuo
COO of IES Diagnostics
Follow Winston P. Kuo:
About IES Diagnostics: IES Diagnostics is a provider of molecular diagnostic tests that redefine disease detection and treatment with accurate diagnosis.
Deborah Woods
Founder, Chief Operating Officer and Partner of Encompass Office Solutions
Deborah Woods served as Chief Operating Officer, Founder and Partner of Encompass Office Solutions, a medical and surgical services company which specialized primarily in gynecology and was the first in-office surgical company in Texas. Prior to that, she served as Surgical Sales Representative from 2004 to 2007 for Senorx, a designer, developer and manufacturer of minimally invasive devices for diagnosis and treatment of breast cancer. From 1999 to 2004, Mrs. Woods held various senior level positions with Novacept, Gynecare, Parke-Davis/Pfizer, and Bristol-Myers Squibb. Mrs. Woods earned a Bachelor’s of Arts in Communications from Baylor University.
Follow Deborah Woods:
About Encompass Office Solutions: Encompass Office Solutions is a U.S.-based provider of in-office procedural services.
Jerry Brightbill
Chief Operating Officer of YourBio Health
Jerry Brightbill is the Chief Operating Officer at YourBio Health.
Follow Jerry Brightbill:
About YourBio Health: YourBio Health optimizes the interface of diagnostic medicine and healthcare consumer by simplifying blood sampling and testing.
Vaughn Ostland
VP/COO of Intrinsic LifeSciences
Follow Vaughn Ostland:
About Intrinsic LifeSciences: Intrinsic LifeSciences LLC, a life sciences company, develops in vitro diagnostic devices for clinical medicine applications
Joe Schachle
Chief Operating Officer of Opus Genetics
Joe Schachle currently serves as our Chief Operating Officer. Mr. Schachle has over 20 years of commercial and corporate leadership experience in the pharmaceutical and biotech industry. Before joining Parion, he served as Head of Global Marketing Operations for Grifols. Prior to Grifols he held several executive positions with Inspire Pharmaceuticals (which was purchased my Merck & Company) including Executive Vice President, Pulmonary Business and Executive Vice President and Chief of Commercial and Corporate Operations.Before his tenure at Inspire, Mr. Schachle held multiple positions with GlaxoSmithKline in sales, marketing, and new product development including responsibility for the successful launch of Advair® in the role of Director of Marketing. Joe also held sales and marketing roles at MedImmune and The Upjohn Company.
Follow Joe Schachle:
About Opus Genetics: Opus Genetics is a gene therapy company for ultra-rare blinding conditions.
Gene Wahnefried
CFO & COO of Advanced Tear Diagnostics (ATD)
Follow Gene Wahnefried:
About Advanced Tear Diagnostics (ATD): Develops and markets a highly specialized point-of-care (POC) lab testing system.
Paul Larson
President, Chief Operating Officer & Director of Daylight Solutions
Paul Larson is a cofounder of Daylight Solutions and serves as the company’s President and COO. He is a seasoned executive with over 25 years’ experience managing business operations and developing leading-edge technologies. Mr. Larson has held senior management positions with successful start-ups such as San Diego-based Applied Micro Circuits Corporation (AMCC), and Qualcomm Inc. As Director of ASIC Programs for Qualcomm, Mr. Larson contributed significantly to the company’s early efforts to establish a commercially viable ASIC division, generating over $600M in revenue during its third year. Mr. Larson also contributed to business operations of larger, global companies such as Ericsson, where he was Director of Business Management. Mr. Larson began his career as an Electrical Engineer with Motorola’s Integrated Circuits Research Applications Laboratory (MICARL). He holds a BSEE from the United States International University and an MBA from San Diego State University.
Follow Paul Larson:
About Daylight Solutions: Daylight Solutions manufactures molecular detection and imaging instruments for diagnostics, homeland security, military and more.
David Steinmiller
Co-founder and COO of Claros Diagnostics
Follow David Steinmiller:
About Claros Diagnostics: Claros Diagnostics develop blood testing devices for use in homes and doctors offices for tests typically performed in a laboratory.
Alex Wieseler
COO of PATH EX
Alex Wieseler serves as Executive Director at PATH EX, Inc.
Follow Alex Wieseler:
About PATH EX: PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood.
Tom Gruber
COO and CFO of CDx Life
Tom has over 20 years of experience in financial and senior executive management from well known, publicly traded technology companies. He has worked as the CFO for Western Digital and as the CFO and COO for I/O Magic. Tom holds an MBA from Pepperdine University.
Follow Tom Gruber:
About CDx Life: MyDx (My Diagnostic) is the world’s first portable analyzer for everyone – a simple and affordable device.